We are live on ! Find out more
CPA

Capital Performance Advisors Portfolio holdings

AUM $1.5B
1-Year Est. Return 21.4%
This Fund
S&P 500
This Quarter Est. Return
+7.04%
1 Year Est. Return
+21.4%
3 Year Est. Return
+61.53%
5 Year Est. Return
10 Year Est. Return
AUM
$329M
AUM Growth
+$65.6M
Cap. Flow
+$47.9M
Cap. Flow %
14.56%
Top 10 Hldgs %
61.59%
Holding
2,901
New
2,799
Increased
53
Reduced
27
Closed
2

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$772K
2
NVDA icon
NVIDIA
NVDA
+$662K
3
AAPL icon
Apple
AAPL
+$589K
4
MSFT icon
Microsoft
MSFT
+$568K
5
AVGO icon
Broadcom
AVGO
+$431K

Sector Composition

Rank Sector Weight
1 Technology 10.08%
2 Financials 4.66%
3 Consumer Discretionary 2.92%
4 Healthcare 2.04%
5 Industrials 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABOS icon
2651
Acumen Pharmaceuticals
ABOS
$159M
$129 ﹤0.01%
+52
New +$141
IPAR icon
2652
Interparfums
IPAR
$3.99B
$129 ﹤0.01%
+1
New +$125
LAW icon
2653
CS Disco
LAW
$248M
$129 ﹤0.01%
+22
New +$123
PLPC icon
2654
Preformed Line Products
PLPC
$1.52B
$128 ﹤0.01%
+1
New +$121
HOWL icon
2655
Werewolf Therapeutics
HOWL
$22M
$127 ﹤0.01%
+60
New +$136
PINE
2656
Alpine Income Property Trust
PINE
$341M
$127 ﹤0.01%
+7
New +$122
RCKY icon
2657
Rocky Brands
RCKY
$313M
$127 ﹤0.01%
+4
New +$127
BOH icon
2658
Bank of Hawaii
BOH
$3.17B
$126 ﹤0.01%
+2
New +$129
OOMA icon
2659
Ooma
OOMA
$571M
$125 ﹤0.01%
+11
New +$109
RGR icon
2660
Sturm, Ruger & Co
RGR
$620M
$125 ﹤0.01%
+3
New +$127
AIP icon
2661
Arteris
AIP
$1.4B
$124 ﹤0.01%
+16
New +$124
POWW icon
2662
Outdoor Holding Co
POWW
$250M
$122 ﹤0.01%
+85
New +$135
CTLP
2663
DELISTED
Cantaloupe
CTLP
$118 ﹤0.01%
+16
New +$110
LRMR icon
2664
Larimar Therapeutics
LRMR
$398M
$118 ﹤0.01%
+18
New +$145
TYRA icon
2665
Tyra Biosciences
TYRA
$1.85B
$118 ﹤0.01%
+5
New +$105
REAX icon
2666
Real Brokerage
REAX
$384M
$117 ﹤0.01%
+21
New +$119
SLAB icon
2667
Silicon Laboratories
SLAB
$7.17B
$116 ﹤0.01%
+1
New +$112
SST icon
2668
System1
SST
$15.7M
$116 ﹤0.01%
+10
New +$128
TMP icon
2669
Tompkins Financial
TMP
$1.43B
$116 ﹤0.01%
+2
New +$114
ALLO icon
2670
Allogene Therapeutics
ALLO
$604M
$115 ﹤0.01%
+41
New +$109
RGNX icon
2671
Regenxbio
RGNX
$622M
$115 ﹤0.01%
+11
New +$134
CSTM icon
2672
Constellium
CSTM
$4.02B
$114 ﹤0.01%
+7
New +$119
HYS icon
2673
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.74B
$113 ﹤0.01%
+1
New +$94
TSVT
2674
DELISTED
2seventy bio
TSVT
$113 ﹤0.01%
+24
New +$108
USHY icon
2675
iShares Broad USD High Yield Corporate Bond ETF
USHY
$29.2B
$113 ﹤0.01%
+3
New +$111

Similar funds

Capital Performance Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Capital Performance Advisors held 2,901 positions worth $329M, up 25% from $263M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Capital Performance Advisors deployed $47.9M of net new capital in Q3 2024, opening 2,799 new positions and adding to 53 existing holdings. Its largest new stake was Broadcom: 2,686 shares worth $463K.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 8.6% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dimensional US Core Equity 2 ETF, an estimated $521K trimmed.

  • Capital Performance Advisors's largest Q3 2024 buy was Broadcom: 2,686 shares worth $463K.
  • Capital Performance Advisors added most to Amazon in Q3 2024, an estimated $772K increase.
  • Capital Performance Advisors's biggest Q3 2024 reduction was Dimensional US Core Equity 2 ETF, cutting an estimated $521K.
  • Capital Performance Advisors fully exited Dimensional US Core Equity 1 ETF in Q3 2024, selling an estimated $497K.
  • Capital Performance Advisors's ten largest holdings make up 62% of its $329M portfolio in Q3 2024.
  • Capital Performance Advisors opened 2,799 new positions and closed 2 in Q3 2024.
  • Capital Performance Advisors's portfolio value rose 25% quarter-over-quarter to $329M.

Based on Capital Performance Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.